FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Odiparcil, 137215-12-4, Odiparcil Intermediate 108-46-3, stock 128g, white powder, assay by HPLC 100%, HNMR, LCMS we supply. |
| Odiparcil, 137215-12-4, Odiparcil Intermediate /, stock 106.8g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
| Odiparcil, 137215-12-4, Odiparcil Intermediate 90-33-5, stock 416.7g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
| Odiparcil, 137215-12-4, Odiparcil Intermediate 130855-73-1, stock 408.2g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Odiparcil, 137215-12-4, Odiparcil Intermediate 137214-79-0, stock 770.5g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
